tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Taysha Gene Therapies rated Buy versus Early-Stage at Goldman Sachs
PremiumThe FlyTaysha Gene Therapies rated Buy versus Early-Stage at Goldman Sachs
3M ago
Taysha price target raised to $19 from $13 at Cantor Fitzgerald
Premium
The Fly
Taysha price target raised to $19 from $13 at Cantor Fitzgerald
3M ago
Citizens JMP healthcare analysts hold an analyst/industry conference
Premium
The Fly
Citizens JMP healthcare analysts hold an analyst/industry conference
3M ago
Taysha Gene Therapies: Advancing REVEAL Study and Mitigating Regulatory Risks Earns Buy Rating
PremiumRatingsTaysha Gene Therapies: Advancing REVEAL Study and Mitigating Regulatory Risks Earns Buy Rating
4M ago
Taysha Gene Therapies files automatic mixed securities shelf
Premium
The Fly
Taysha Gene Therapies files automatic mixed securities shelf
4M ago
Taysha Gene Therapies Amends Sales Agreement, Expands Offering
Premium
Company Announcements
Taysha Gene Therapies Amends Sales Agreement, Expands Offering
4M ago
Taysha Gene Therapies initiated with a Strong Buy at Raymond James
PremiumThe FlyTaysha Gene Therapies initiated with a Strong Buy at Raymond James
4M ago
Strategic Advantage and Positive Outlook: Taysha Gene Therapies Maintains Buy Rating
Premium
Ratings
Strategic Advantage and Positive Outlook: Taysha Gene Therapies Maintains Buy Rating
4M ago
Taysha Regains Full Rights to TSHA-102 Program
Premium
Company Announcements
Taysha Regains Full Rights to TSHA-102 Program
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100